PRIVACY POLICY Last updated March 30, 2022 This privacy notice for Ethiopian Food and Drug Authority (doing business as EFDA) (“EFDA,” “we,” “us,” or “our”), describes how and why we might collect, store, use, and/or share (“process”) your information when you use our services (“Services”), such as when you: Visit our website at www.efda.gov.et, or…
Hemlibra_Emicizumab_ Summary of product characteristics v1
Hemlibra_Emicizumab_ Public assessment summary reportv1
Lumerax DT 20120_ Artemether 20 mg & Lumefantrine 120 mg Dispersible_public assessment summary report
Lumerax DT 20120_ Artemether 20 mg & Lumefantrine 120 mg Dispersible_Summary of product characteristics
INIGAST 40 Summary of product characteristics v1
ALLTERA 50 Summary of product characteristics v1
Food and Medicine Administration Proclamation 1112
